K. Stephen Suh
Biography
As scientific director of the Tissue Bank, K. Stephen Suh, Ph.D., manages The
Cancer Center’s Tissue Repository and the Genomics and
Biomarkers Program for multiple human
cancer types. The Tissue Bank stores tissue, blood, or
bone marrow samples that have been taken from patients who have undergone biopsies, surgery, or other procedures for
cancer. Scientists use these samples to analyze and study
cancer cells. Dr. Suh’s laboratory focuses on genomics (differences in gene expression), proteinomics (differences in protein make-up) and tissueomics (differences in tissue structure and marker expressions at the tissue level) by analyzing
cancer cells and normal cells. This research centers on identifying
biomarkers (details of a person’s genetic make-up) for
cancer that will ultimately guide scientists to correctly diagnose
cancer at the molecular level. Physicians can then use this knowledge to prescribe optimal treatment based on a patient’s “personalized” medical condition and the presence of specific molecular markers.
Biomarkers can also be used to determine quickly how well a treatment is working so that it can be adjusted if necessary. Dr. Suh has been conducting research in molecular and
cell biology for almost 20 years. After completing a master of science degree and doctorate in molecular and
cell biology at the University of Texas, he was a post-doctoral fellow and then research fellow/staff member at the National
Cancer Institute for nine years. He was recruited to join The
Cancer Center at Hackensack University Medical Center in 2007. He has received a number of awards for his research and has been published in leading medical and research journals, including Gene, Molecular and Cell Biology, Genomics, and
Cancer Research.
Research Interest
Biomarkers for lymphoma and ovarian cancer; genomics, proteinomics, and tissueomics for multiple human cancer types.